← Leaderboards
Salvatore Mascia
Continuus Pharmaceuticals, Inc.
$1,408,000
Attributed
$1,408,000
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2015–16$2M$1.5M$1M$500K$0
'15
'16
Funding mix
By agency
NSF$1,408,000 · 2
By mechanism
—$1,408,000 · 2
Top collaborators
No co-investigators on record.
Grant awards (2)
SBIR Phase II: Novel pharmaceutical manufacturing technologies to deliver more affordable medications to patients faster and with better quality$1,258,000
· FY2016 · TIP · contact PI
SBIR Phase I: Novel pharmaceutical manufacturing technologies to deliver more affordable medications to patients faster and with better quality$150,000
· FY2015 · TIP · contact PI